News

Ms Roberts joined Bausch & Lomb in 1995 after several years in private practice as a trial lawyer at Harter, Secrest & Emery. Ms Roberts then held positions

Built on the novel and proprietary Seeplex molecular diagnostic platform that delivers maximum specificity, reproducibility and sensitivity, the Canadian healthcare system can now use the RV5 and RV12

Under the agreement The Automation Partnership (TAP) will co-develop and manufacture the DynaflowHT system, Cellectricon’s next generation high throughput ion channel screening platform. DynaflowHT will be launched and

Takeda has also ended the collaboration agreement with Cell Genesys for the development and commercialization of the product. Under the terms of the agreement, Takeda will return all

The trial data shows that patients receiving NX-1207 recorded significant quantitative improvement in the important symptoms of urgent need to urinate, and of frequency of urination. Compared to

The randomized, double-blind, controlled study is designed to demonstrate that the single-injection Monovisc safely provides symptomatic relief of knee pain in patients with osteoarthritis. Anika enrolled approximately 350

The PLAC test is said to be the only blood test cleared by the FDA to assess risk for both coronary heart disease and ischemic stroke associated with

Mr Miclot is currently the president and CEO of CCS Medical, a provider of various home care products for chronic diseases such as diabetes, wound care, urology and

Dr Garceau replaces Alan Harris who is leaving NPS for personal reasons but remains as a scientific advisor to the company. Dr Garceau joins NPS from Sanofi-Aventis, where